New Zealand

Eisai New Zealand Ltd is a member of Medicines New Zealand and as such supports transparency around the interactions between healthcare professionals and the pharmaceutical industry. The purpose of introducing disclosure of payments is to ensure that the interactions between Healthcare Professionals and the biopharmaceutical industry are better understood by the public of New Zealand. This disclosure leads to increasing trust and confidence in the community that any activities undertaken between the Healthcare Professionals and the medicines industry both support patient care and increase medical knowledge.

Reporting periods are based on calendar year and commenced 1 January 2021. Transparency reports are published within the first 6 months following the end of the previous reporting period.

Transparency Reports

Eisai is committed to maintaining transparency of its relationships with healthcare professionals and patient advocacy organisations.

Please see below for annual transparency reports. Reports will be made available here within 6 months following the end of the previous reporting year.

human health care

hhc helps to focus and motivate all of us who work here at Eisai, whether we are researching potential new medicines, conducting studies, working in manufacturing or informing healthcare professionals about our medicines.